Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma

Summary

The primary purpose of the study is to determine the proportion of patients without progression at 6-months in patients with unresectable Stage III or Stage IV melanoma who are taking RTA 402.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications